S&P 500   4,981.80
DOW   38,612.24
QQQ   425.61
Palo Alto Networks, Keysight fall; Garmin, Toll Brothers rise, Wednesday, 2/21/2024
Is Gold Really Boring? (Ad)
Palo Alto Networks aims at cyber security leadership
3 Reasons the Capital One-Discover merger is a big deal
Is Gold Really Boring? (Ad)
How major US stock indexes fared Wednesday, 2/21/2024
Germany says Europe's largest economy is in 'troubled waters' and cuts its growth forecast
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
Housing data weakens, but Toll Brothers stock is still a buy
Teladoc Health gaps down to support level after weak guidance
S&P 500   4,981.80
DOW   38,612.24
QQQ   425.61
Palo Alto Networks, Keysight fall; Garmin, Toll Brothers rise, Wednesday, 2/21/2024
Is Gold Really Boring? (Ad)
Palo Alto Networks aims at cyber security leadership
3 Reasons the Capital One-Discover merger is a big deal
Is Gold Really Boring? (Ad)
How major US stock indexes fared Wednesday, 2/21/2024
Germany says Europe's largest economy is in 'troubled waters' and cuts its growth forecast
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
Housing data weakens, but Toll Brothers stock is still a buy
Teladoc Health gaps down to support level after weak guidance
S&P 500   4,981.80
DOW   38,612.24
QQQ   425.61
Palo Alto Networks, Keysight fall; Garmin, Toll Brothers rise, Wednesday, 2/21/2024
Is Gold Really Boring? (Ad)
Palo Alto Networks aims at cyber security leadership
3 Reasons the Capital One-Discover merger is a big deal
Is Gold Really Boring? (Ad)
How major US stock indexes fared Wednesday, 2/21/2024
Germany says Europe's largest economy is in 'troubled waters' and cuts its growth forecast
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
Housing data weakens, but Toll Brothers stock is still a buy
Teladoc Health gaps down to support level after weak guidance
S&P 500   4,981.80
DOW   38,612.24
QQQ   425.61
Palo Alto Networks, Keysight fall; Garmin, Toll Brothers rise, Wednesday, 2/21/2024
Is Gold Really Boring? (Ad)
Palo Alto Networks aims at cyber security leadership
3 Reasons the Capital One-Discover merger is a big deal
Is Gold Really Boring? (Ad)
How major US stock indexes fared Wednesday, 2/21/2024
Germany says Europe's largest economy is in 'troubled waters' and cuts its growth forecast
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
Housing data weakens, but Toll Brothers stock is still a buy
Teladoc Health gaps down to support level after weak guidance

Ryan Specialty (RYAN) Competitors

$45.74
-0.57 (-1.23%)
(As of 02/21/2024 ET)

RYAN vs. EQH, ERIE, GSHD, BRP, BRO, WTW, UDR, BCH, REG, and RNR

Should you be buying Ryan Specialty stock or one of its competitors? The main competitors of Ryan Specialty include Equitable (EQH), Erie Indemnity (ERIE), Goosehead Insurance (GSHD), BRP Group (BRP), Brown & Brown (BRO), Willis Towers Watson Public (WTW), UDR (UDR), Banco de Chile (BCH), Regency Centers (REG), and RenaissanceRe (RNR). These companies are all part of the "finance" sector.

Ryan Specialty vs.

Equitable (NYSE:EQH) and Ryan Specialty (NYSE:RYAN) are both large-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, risk, community ranking, analyst recommendations, dividends, media sentiment, institutional ownership and profitability.

Equitable has higher revenue and earnings than Ryan Specialty. Equitable is trading at a lower price-to-earnings ratio than Ryan Specialty, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Equitable$10.53B1.10$1.14B$3.3810.09
Ryan Specialty$1.73B6.90$61.05M$0.4797.32

Equitable received 231 more outperform votes than Ryan Specialty when rated by MarketBeat users. Likewise, 60.19% of users gave Equitable an outperform vote while only 37.74% of users gave Ryan Specialty an outperform vote.

CompanyUnderperformOutperform
EquitableOutperform Votes
251
60.19%
Underperform Votes
166
39.81%
Ryan SpecialtyOutperform Votes
20
37.74%
Underperform Votes
33
62.26%

92.7% of Equitable shares are held by institutional investors. Comparatively, 34.1% of Ryan Specialty shares are held by institutional investors. 1.0% of Equitable shares are held by company insiders. Comparatively, 54.5% of Ryan Specialty shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Equitable has a beta of 1.41, indicating that its share price is 41% more volatile than the S&P 500. Comparatively, Ryan Specialty has a beta of 0.42, indicating that its share price is 58% less volatile than the S&P 500.

Ryan Specialty has a net margin of 9.18% compared to Ryan Specialty's net margin of 0.00%. Equitable's return on equity of 42.39% beat Ryan Specialty's return on equity.

Company Net Margins Return on Equity Return on Assets
EquitableN/A N/A N/A
Ryan Specialty 9.18%42.39%5.78%

Equitable currently has a consensus target price of $35.00, suggesting a potential upside of 2.65%. Ryan Specialty has a consensus target price of $51.14, suggesting a potential upside of 11.81%. Given Equitable's higher probable upside, analysts clearly believe Ryan Specialty is more favorable than Equitable.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Equitable
0 Sell rating(s)
4 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.56
Ryan Specialty
0 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.43

In the previous week, Ryan Specialty had 2 more articles in the media than Equitable. MarketBeat recorded 9 mentions for Ryan Specialty and 7 mentions for Equitable. Ryan Specialty's average media sentiment score of 0.86 beat Equitable's score of 0.49 indicating that Equitable is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Equitable
4 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Ryan Specialty
3 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Equitable beats Ryan Specialty on 10 of the 18 factors compared between the two stocks.


Get Ryan Specialty News Delivered to You Automatically

Sign up to receive the latest news and ratings for RYAN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RYAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RYAN vs. The Competition

MetricRyan SpecialtyInsurance agents, brokers, & service IndustryFinance SectorNYSE Exchange
Market Cap$12.05B$18.87B$7.92B$17.27B
Dividend YieldN/A2.38%10.36%3.57%
P/E Ratio97.3222.8758.1720.75
Price / Sales6.9019.393,592.245.65
Price / Cash27.5244.4729.6017.89
Price / Book14.5710.632.176.30
Net Income$61.05M$855.14M$792.33M$869.26M
7 Day Performance0.57%-0.85%-0.71%-1.23%
1 Month Performance2.65%6.95%-0.54%1.52%
1 Year Performance6.79%52.26%3.73%76.11%

Ryan Specialty Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EQH
Equitable
3.915 of 5 stars
$33.12
-2.9%
$35.00
+5.7%
+8.8%$11.21B$10.53B9.8012,300
ERIE
Erie Indemnity
3.2784 of 5 stars
$349.47
-1.6%
N/A+46.1%$18.28B$2.84B45.626,038Upcoming Earnings
GSHD
Goosehead Insurance
2.4216 of 5 stars
$84.00
-1.3%
$81.88
-2.5%
+129.0%$3.18B$209.39M186.671,427News Coverage
BRP
BRP Group
1.564 of 5 stars
$24.59
-1.2%
$27.25
+10.8%
-6.5%$2.87B$980.72M-13.893,888Upcoming Earnings
News Coverage
High Trading Volume
BRO
Brown & Brown
4.5672 of 5 stars
$80.95
+0.0%
$82.70
+2.2%
+47.3%$23.04B$4.26B26.4515,201
WTW
Willis Towers Watson Public
3.9922 of 5 stars
$270.86
-0.5%
$284.36
+5.0%
+16.0%$27.97B$9.48B27.0346,600Analyst Revision
Positive News
UDR
UDR
4.4789 of 5 stars
$34.62
-2.7%
$42.69
+23.3%
-17.2%$11.39B$1.63B25.841,326Analyst Downgrade
BCH
Banco de Chile
1.8744 of 5 stars
$22.24
-0.9%
$22.50
+1.2%
+9.6%$11.23B$5.30B7.4112,550
REG
Regency Centers
4.809 of 5 stars
$60.42
-0.5%
$71.80
+18.8%
-2.7%$11.15B$1.32B29.62440
RNR
RenaissanceRe
3.5601 of 5 stars
$227.75
+0.7%
$240.90
+5.8%
+5.6%$11.65B$9.13B4.45718Analyst Revision

Related Companies and Tools

This page (NYSE:RYAN) was last updated on 2/22/2024 by MarketBeat.com Staff